These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 2168835)
1. Antidepressant-like activity of the melatonin receptor antagonist, luzindole (N-0774), in the mouse behavioral despair test. Dubocovich ML; Mogilnicka E; Areso PM Eur J Pharmacol; 1990 Jul; 182(2):313-25. PubMed ID: 2168835 [TBL] [Abstract][Full Text] [Related]
2. The antidepressant-like effect of the melatonin receptor ligand luzindole in mice during forced swimming requires expression of MT2 but not MT1 melatonin receptors. Sumaya IC; Masana MI; Dubocovich ML J Pineal Res; 2005 Sep; 39(2):170-7. PubMed ID: 16098095 [TBL] [Abstract][Full Text] [Related]
3. Activation of melatonin receptor sites retarded the depletion of norepinephrine following inhibition of synthesis in the C3H/HeN mouse hypothalamus. Fang JM; Dubocovich ML J Neurochem; 1990 Jul; 55(1):76-82. PubMed ID: 2162381 [TBL] [Abstract][Full Text] [Related]
4. Anti-depressant action of melatonin in chronic forced swimming-induced behavioral despair in mice, role of peripheral benzodiazepine receptor modulation. Raghavendra V; Kaur G; Kulkarni SK Eur Neuropsychopharmacol; 2000 Dec; 10(6):473-81. PubMed ID: 11115737 [TBL] [Abstract][Full Text] [Related]
5. Melatonin affects the immobility time of rats in the forced swim test: the role of serotonin neurotransmission. Micale V; Arezzi A; Rampello L; Drago F Eur Neuropsychopharmacol; 2006 Oct; 16(7):538-45. PubMed ID: 16527463 [TBL] [Abstract][Full Text] [Related]
7. Melatonin receptors mediate improvements of survival in a model of polymicrobial sepsis. Fink T; Glas M; Wolf A; Kleber A; Reus E; Wolff M; Kiefer D; Wolf B; Rensing H; Volk T; Mathes AM Crit Care Med; 2014 Jan; 42(1):e22-31. PubMed ID: 24145838 [TBL] [Abstract][Full Text] [Related]
8. On the mechanism of antidepressant-like action of berberine chloride. Kulkarni SK; Dhir A Eur J Pharmacol; 2008 Jul; 589(1-3):163-72. PubMed ID: 18585703 [TBL] [Abstract][Full Text] [Related]
9. Possible involvement of L-arginine-nitric oxide (NO)-cyclic guanosine monophosphate (cGMP) signaling pathway in the antidepressant activity of berberine chloride. Kulkarni SK; Dhir A Eur J Pharmacol; 2007 Aug; 569(1-2):77-83. PubMed ID: 17585901 [TBL] [Abstract][Full Text] [Related]
10. Quinone reductase 2 and antidepressant effect of melatonin derivatives. Oxenkrug GF; Bachurin SO; Prakhie IV; Zefirov NS Ann N Y Acad Sci; 2010 Jun; 1199():121-4. PubMed ID: 20633117 [TBL] [Abstract][Full Text] [Related]
11. Effects of melatonin receptor ligands on swim test immobility. Overstreet DH; Pucilowski O; Retton MC; Delagrange P; Guardiola-Lemaitre B Neuroreport; 1998 Jan; 9(2):249-53. PubMed ID: 9507964 [TBL] [Abstract][Full Text] [Related]
13. Effect of antidepressant drugs in mice lacking the norepinephrine transporter. Dziedzicka-Wasylewska M; Faron-Górecka A; Kuśmider M; Drozdowska E; Rogóz Z; Siwanowicz J; Caron MG; Bönisch H Neuropsychopharmacology; 2006 Nov; 31(11):2424-32. PubMed ID: 16554743 [TBL] [Abstract][Full Text] [Related]
14. The influence od melatonin receptors antagonists, luzindole and 4-phenyl-2-propionamidotetralin (4-P-PDOT), on melatonin-dependent vasopressin and adrenocorticotropic hormone (ACTH) release from the rat hypothalamo-hypophysial system. In vitro and in vivo studies. Juszczak M; Roszczyk M; Kowalczyk E; Stempniak B J Physiol Pharmacol; 2014 Dec; 65(6):777-84. PubMed ID: 25554981 [TBL] [Abstract][Full Text] [Related]
15. Chronic administration of a melatonin membrane receptor antagonist, luzindole, affects hippocampal neurogenesis without changes in hopelessness-like behavior in adult mice. Ortiz-López L; Pérez-Beltran C; Ramírez-Rodríguez G Neuropharmacology; 2016 Apr; 103():211-21. PubMed ID: 26686389 [TBL] [Abstract][Full Text] [Related]
16. Stimulation of dopamine D-2 but not D-1 receptors reduces immobility time of rats in the forced swimming test: implication for antidepressant activity. Borsini F; Lecci A; Mancinelli A; D'Aranno V; Meli A Eur J Pharmacol; 1988 Apr; 148(3):301-7. PubMed ID: 2968270 [TBL] [Abstract][Full Text] [Related]
17. The melatonin receptor antagonist luzindole induces Ca Estaras M; Ameur FZ; Roncero V; Fernandez-Bermejo M; Blanco G; Lopez D; Mateos JM; Salido GM; Gonzalez A Biochim Biophys Acta Gen Subj; 2019 Nov; 1863(11):129407. PubMed ID: 31381958 [TBL] [Abstract][Full Text] [Related]
18. Diurnal changes of tonic nociceptive responses in mice: evidence for a proalgesic role of melatonin. Perissin L; Boccalon S; Scaggiante B; Petrelli L; Ortolani F; Porro CA Pain; 2004 Jul; 110(1-2):250-8. PubMed ID: 15275775 [TBL] [Abstract][Full Text] [Related]
19. Combination therapy of imipramine and melatonin: additive antidepressant effect in mouse forced swimming test. Ergün Y; Orhan FO; Karaaslan MF Eur J Pharmacol; 2008 Sep; 591(1-3):159-63. PubMed ID: 18601918 [TBL] [Abstract][Full Text] [Related]
20. The melatonin antagonist luzindole protects retinal photoreceptors from light damage in the rat. Sugawara T; Sieving PA; Iuvone PM; Bush RA Invest Ophthalmol Vis Sci; 1998 Nov; 39(12):2458-65. PubMed ID: 9804154 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]